{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:08:34Z","timestamp":1756994914685,"version":"3.40.3"},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":11470,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1981,3]]},"abstract":"<jats:p>1 A \u2018GSH (reduced glutathione) stability test\u2019 which consists of incubating blood samples with acetylphenylhydrazine and other test drugs and measuring GSH level before and after incubation, was carried out. 2 Application of this test to the blood of eight normal volunteers and twelve known G\u20106\u2010PD deficient persons demonstrated that acetylphenylhydrazine and primaquine produced a significant decrease in GSH levels in G\u20106\u2010PD deficient red cells compared to the reduction seen in normal red cells incubated with these drugs. No such change was observed with aspirin, ibuprofen and flurbiprofen. 3 The results of this in vitro study seem to indicate that ibuprofen and flurbiprofen are relatively innocuous in G\u20106\u2010PD deficient individuals.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1981.tb00529.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T16:27:24Z","timestamp":1343320044000},"page":"251-253","source":"Crossref","is-referenced-by-count":1,"title":["Tolerability of ibuprofen and flurbiprofen in G\u20106\u2010PD deficient subjects: in vitro study."],"prefix":"10.1111","volume":"11","author":[{"given":"UK","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SP","family":"Valame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KC","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AJ","family":"Baxi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VN","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PK","family":"Pispati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"493","article-title":"Glucose\u20106\u2010phosphate dehydrogenase deficiency in Parsee community, Bombay","volume":"16","author":"BAXI A.J.","year":"1963","journal-title":"Indian J. med. Sci."},{"key":"e_1_2_1_3_1","first-page":"215","volume-title":"Medical Genetics in India","author":"BAXI A.J.","year":"1978"},{"key":"e_1_2_1_4_1","first-page":"84","article-title":"The glutathione instability of drug\u2010sensitive red cells","volume":"49","author":"BEUTLER E.","year":"1957","journal-title":"J. lab. clin. Med."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0031-6997(25)06872-3","article-title":"Drug\u2010induced haemolytic anaemia","volume":"21","author":"BEUTLER E.","year":"1969","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_6_1","first-page":"286","article-title":"The hemolytic effect of primaquine. VII biochemical studies of drug\u2010sensitive erythrocytes","volume":"45","author":"BEUTLER E.","year":"1955","journal-title":"J. lab. clin. Med."},{"key":"e_1_2_1_7_1","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"BEUTLER E.","year":"1965","journal-title":"J. lab. clin. Med."},{"key":"e_1_2_1_8_1","first-page":"442","volume-title":"Principles of Drug Action","author":"GOLDSTEIN A.","year":"1969"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106349"},{"key":"e_1_2_1_10_1","unstructured":"WHO(1967).Standardization of procedures for the study of glucose\u20106\u2010phosphate dehydrogenase.Technical Report Series No.366 4\u201333."}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1981.tb00529.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1981.tb00529.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:25:53Z","timestamp":1743863153000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1981.tb00529.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981,3]]}},"alternative-id":["10.1111\/j.1365-2125.1981.tb00529.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb00529.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[1981,3]]}}}